{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:31:17Z","timestamp":1790854277908,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T00:00:00Z","timestamp":1289174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T00:00:00Z","timestamp":1289174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2011,3,17]]},"DOI":"10.1038\/onc.2010.515","type":"journal-article","created":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T11:19:03Z","timestamp":1289215143000},"page":"1329-1340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma"],"prefix":"10.1038","volume":"30","author":[{"given":"L","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"Kornblau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Graber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D M","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S K","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Muddasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-Y","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K A","family":"Baggerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Z","family":"Orlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,8]]},"reference":[{"key":"BFonc2010515_CR1","doi-asserted-by":"publisher","first-page":"11799","DOI":"10.1074\/jbc.273.19.11799","volume":"273","author":"T Arora","year":"1998","unstructured":"Arora T, Jelinek DF . (1998). Differential myeloma cell responsiveness to interferon-alpha correlates with differential induction of p19(INK4d) and cyclin D2 expression. J Biol Chem 273: 11799\u201311805.","journal-title":"J Biol Chem"},{"key":"BFonc2010515_CR2","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1200\/JCO.2005.05.021","volume":"23","author":"PL Bergsagel","year":"2005","unstructured":"Bergsagel PL, Kuehl WM . (2005). Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 23: 6333\u20136338.","journal-title":"J Clin Oncol"},{"key":"BFonc2010515_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","volume":"106","author":"PL Bergsagel","year":"2005","unstructured":"Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy Jr J . (2005). Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 106: 296\u2013303.","journal-title":"Blood"},{"key":"BFonc2010515_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ccr.2006.03.019","volume":"9","author":"DR Carrasco","year":"2006","unstructured":"Carrasco DR, Tonon G, Huang Y, Zhang Y, Sinha R, Feng B et al. (2006). High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 9: 313\u2013325.","journal-title":"Cancer Cell"},{"key":"BFonc2010515_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1365-2141.2006.06325.x","volume":"135","author":"H Chang","year":"2006","unstructured":"Chang H, Qi X, Trieu Y, Xu W, Reader JC, Ning Y et al. (2006). Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation. Br J Haematol 135: 486\u2013491.","journal-title":"Br J Haematol"},{"key":"BFonc2010515_CR6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V88.2.674.bloodjournal882674","volume":"88","author":"M Chesi","year":"1996","unstructured":"Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM . (1996). Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 88: 674\u2013681.","journal-title":"Blood"},{"key":"BFonc2010515_CR7","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood.V91.12.4457.412k48_4457_4463","volume":"91","author":"M Chesi","year":"1998","unstructured":"Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T et al. (1998a). Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91: 4457\u20134463.","journal-title":"Blood"},{"key":"BFonc2010515_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/ng0797-260","volume":"16","author":"M Chesi","year":"1997","unstructured":"Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM et al. (1997). Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16: 260\u2013264.","journal-title":"Nat Genet"},{"key":"BFonc2010515_CR9","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood.V92.9.3025","volume":"92","author":"M Chesi","year":"1998","unstructured":"Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL . (1998b). The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH\/MMSET hybrid transcripts. Blood 92: 3025\u20133034.","journal-title":"Blood"},{"key":"BFonc2010515_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0165-4608(84)90036-0","volume":"12","author":"A Ferti","year":"1984","unstructured":"Ferti A, Panani A, Arapakis G, Raptis S . (1984). Cytogenetic study in multiple myeloma. Cancer Genet Cytogenet 12: 247\u2013253.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFonc2010515_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1097-2765(00)80180-X","volume":"3","author":"A Gabrea","year":"1999","unstructured":"Gabrea A, Bergsagel PL, Chesi M, Shou Y, Kuehl WM . (1999). Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. Mol Cell 3: 119\u2013123.","journal-title":"Mol Cell"},{"key":"BFonc2010515_CR12","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1182\/blood-2004-04-1319","volume":"104","author":"NC Gutierrez","year":"2004","unstructured":"Gutierrez NC, Garcia JL, Hernandez JM, Lumbreras E, Castellanos M, Rasillo A et al. (2004). Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma. Blood 104: 2661\u20132666.","journal-title":"Blood"},{"key":"BFonc2010515_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrc2189","volume":"7","author":"T Hideshima","year":"2007","unstructured":"Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC . (2007). Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 7: 585\u2013598.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2010515_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1535-6108(04)00019-4","volume":"5","author":"EM Hurt","year":"2004","unstructured":"Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T et al. (2004). Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell 5: 191\u2013199.","journal-title":"Cancer Cell"},{"key":"BFonc2010515_CR15","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1182\/blood-2007-01-065888","volume":"110","author":"DJ Kuhn","year":"2007","unstructured":"Kuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM et al. (2007). Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma. Blood 110: 3281\u20133290.","journal-title":"Blood"},{"key":"BFonc2010515_CR16","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/sj.leu.2403084","volume":"17","author":"S Kumar","year":"2003","unstructured":"Kumar S, Witzig TE, Timm M, Haug J, Wellik L, Fonseca R et al. (2003). Expression of VEGF and its receptors by myeloma cells. Leukemia 17: 2025\u20132031.","journal-title":"Leukemia"},{"key":"BFonc2010515_CR17","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle RA, Rajkumar SV . (2008). Multiple myeloma. Blood 111: 2962\u20132972.","journal-title":"Blood"},{"key":"BFonc2010515_CR18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3324\/haematol.11052","volume":"92","author":"C Largo","year":"2007","unstructured":"Largo C, Saez B, Alvarez S, Suela J, Ferreira B, Blesa D et al. (2007). Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations. Haematologica 92: 795\u2013802.","journal-title":"Haematologica"},{"key":"BFonc2010515_CR19","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1182\/blood-2004-05-1760","volume":"104","author":"S Le Gouill","year":"2004","unstructured":"Le Gouill S, Podar K, Amiot M, Hideshima T, Chauhan D, Ishitsuka K et al. (2004). VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis. Blood 104: 2886\u20132892.","journal-title":"Blood"},{"key":"BFonc2010515_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cancergencyto.2009.08.021","volume":"196","author":"G Lu","year":"2010","unstructured":"Lu G, Kong Y, Yue C . (2010). Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 196: 56\u201363.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFonc2010515_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12032-008-9066-y","volume":"25","author":"O Markovic","year":"2008","unstructured":"Markovic O, Marisavljevic D, Cemerikic V, Vidovic A, Perunicic M, Todorovic M et al. (2008). Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance. Med Oncol 25: 451\u2013457.","journal-title":"Med Oncol"},{"key":"BFonc2010515_CR22","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1182\/blood.V91.9.3366","volume":"91","author":"JA Perez-Simon","year":"1998","unstructured":"Perez-Simon JA, Garcia-Sanz R, Tabernero MD, Almeida J, Gonzalez M, Fernandez-Calvo J et al. (1998). Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes. Blood 91: 3366\u20133371.","journal-title":"Blood"},{"key":"BFonc2010515_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1182\/blood.V98.2.428","volume":"98","author":"K Podar","year":"2001","unstructured":"Podar K, Tai YT, Davies FE, Lentzsch S, Sattler M, Hideshima T et al. (2001). Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration. Blood 98: 428\u2013435.","journal-title":"Blood"},{"key":"BFonc2010515_CR24","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1160\/TH04-06-0334","volume":"92","author":"R Ria","year":"2004","unstructured":"Ria R, Vacca A, Russo F, Cirulli T, Massaia M, Tosi P et al. (2004). A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma. Thromb Haemost 92: 1438\u20131445.","journal-title":"Thromb Haemost"},{"key":"BFonc2010515_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jcp.2005.034389","volume":"60","author":"GC Santos","year":"2007","unstructured":"Santos GC, Zielenska M, Prasad M, Squire JA . (2007). Chromosome 6p amplification and cancer progression. J Clin Pathol 60: 1\u20137.","journal-title":"J Clin Pathol"},{"key":"BFonc2010515_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1182\/blood.V98.1.217","volume":"98","author":"J Shaughnessy Jr","year":"2001","unstructured":"Shaughnessy Jr J, Gabrea A, Qi Y, Brents L, Zhan F, Tian E et al. (2001). Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma. Blood 98: 217\u2013223.","journal-title":"Blood"},{"key":"BFonc2010515_CR27","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1158\/1078-0432.CCR-07-1293","volume":"13","author":"PM Voorhees","year":"2007","unstructured":"Voorhees PM, Chen Q, Kuhn DJ, Small GW, Hunsucker SA, Strader JS et al. (2007). Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma. Clin Cancer Res 13: 6469\u20136478.","journal-title":"Clin Cancer Res"},{"key":"BFonc2010515_CR28","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1158\/0008-5472.CAN-08-0407","volume":"68","author":"L Yang","year":"2008","unstructured":"Yang L, Hamilton SR, Sood A, Kuwai T, Ellis L, Sanguino A et al. (2008a). The previously undescribed ZKSCAN3 (ZNF306) is a novel \u2018driver\u2019 of colorectal cancer progression. Cancer Res 68: 4321\u20134330.","journal-title":"Cancer Res"},{"key":"BFonc2010515_CR29","doi-asserted-by":"publisher","first-page":"35295","DOI":"10.1074\/jbc.M806965200","volume":"283","author":"L Yang","year":"2008","unstructured":"Yang L, Zhang L, Wu Q, Boyd DD . (2008b). Unbiased Screening for Transcriptional Targets of ZKSCAN3 Identifies Integrin {beta}4 and Vascular Endothelial Growth Factor as Downstream Targets. J Biol Chem 283: 35295\u201335304.","journal-title":"J Biol Chem"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2010515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010515","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:22:21Z","timestamp":1647883341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2010515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,8]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,3,17]]}},"alternative-id":["BFonc2010515"],"URL":"https:\/\/doi.org\/10.1038\/onc.2010.515","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,8]]},"assertion":[{"value":"2 June 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}